In the specialized field of biochemical research, exploring the structural nuances of synthetic compounds is essential for understanding their potential utility. As a long-time observer in the realm of experimental peptides, I have found that examining the specific architecture of molecules like the sequence of CN-105 peptide provides a fascinating glimpse into how small-chain by B Lei · 2016 · Cited by 52 — CN-105, a pentapeptide derived from the polar binding face of the apoE receptor binding region, easily cross BBB, reduces gliosis and cerebral structures can mimic complex biological functions.
Understanding the Architecture of CN-105
When we analyze the Over the past 20 years, have developed an ApoE4 based peptide drug (CN-105), which blocks both AD pathologic progression and neuroinflammatory changes in structural integrity of this compound, we are looking at a highly specialized pentapeptide. My personal experience with such reagents suggests that the precision of the amino acid sequence is the defining factor in its stability and potential interaction profiles.
The CN-105 molecule is an apoE-mimetic 5 amino acid peptide, which is derived from the polar binding face of the apoE helical domain. For those tracking the specific chemical nomenclature, the CN-105 is the pentapeptide having a sequence of Ac-VSRR 1 CN-105. CN-105 is the pentapeptide having a sequence of Ac-VSRRR-amide developed by the AegisCN (NCT03168581). CN-105 mimics the ApoE (polar face) helical R-amide. This notation is critical for researchers, as it denotes:
* Ac: An Acetyl group at the N-terminus.
* VSRRR: The sequence of Valine, Serine, Arginine, Arginine, and Arginine.
* Amide (NH2): The C-terminal modification.
In my review of various laboratory datasets, the clarity of this sequence—often referred to as ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury Ac-VS-RRR-NH2—remains the gold standard for verifying the authenticity of this 105 peptide.
Structural Significance and Propert by TM Tu · 2017 · Cited by 49 — CN‐105 is an apoE‐mimetic 5 amino acid peptide (acetyl‐Valine‐Serine‐Arginine‐Arginine‐Arginine‐amide) derived from the apoE receptor binding ies
The CN-105 represents an apoE mimetic peptide designed to mirror the functional characteristics of the apolipoprotein E receptor-binding region. Because it is a short peptide, it possesses unique physical properties, including its ability to navigate complex environments.
Through my ongoing evaluation of literature, it is clear that the CN designation is often associated with these specific research-grade materials. The 105 integer identifies this particular variant within a broader class of mimetic agents. What makes this peptide CN variant particularly interesting to enthusiasts is its high degree of solubility and its specific polar face configuration, which is a hallmark of its design.
Practical Observations on Sequence Integrity
When sourcing or analyzing this material, maintaining the structural integrity of the Ac-VSRRR-amide sequence is paramount. Even minor deviations in the sequence can alter the properties of the CN-105 molecule. My personal approach to handling such compounds involves verifying the Certificate of Analysis (CoA) to ensure the mass spectrometry results align with the expected molecular weight corresponding to its pentapeptide structure.
It is important to reiterate that while I share these insights based on my personal engagement with research chemicals, these materials are strictly for laboratory and analytical use. They are not intended for human consumption, diagnostics, or therapeutic management. My focus remains on the structural beauty and the precise engineering of these sequences.
Summary of Findings
The study of the sequence of CN-105 peptide serves as a prime example of how modern biochemistry allows us to distill complex protein receptor-binding domains into a manageable pentapeptide. Whether you are examining the CN classification or the specific 105 peptide configuration, the consistency of the Ac-VSRRR-amide sequence is what facilitates the reproducibility of experiments. by DT Laskowitz · 2017 · Cited by 65 — To address this limitation, we developed a small 5 amino acid apoE mimetic peptide(CN-105) that mimics the polar face of the apoE helical domain
By grounding our understanding in these verifiable structural details, we gain a deeper app Duke University reciation for the logic behind these synthetic mimetic agents. As with any high-quality research material, the value lies in the purity and the strict adherence to the defined molecular sequence.